{
  "slug": "alchemi",
  "name": "Alchemi",
  "description": "Alchemi develops purpose-built AI agents and a platform designed to accelerate drug development processes by automating tasks, streamlining documentation, and ensuring compliance in regulated environments for the pharmaceutical and biotech industries.",
  "url": "https://optimly.ai/brand/alchemi",
  "websiteUrl": "https://alchemi.bio/",
  "logoUrl": "https://logo.clearbit.com/alchemi.bio",
  "baiScore": 52.5,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": null,
  "archetype_status": "active",
  "category": "AI Clinical Development Optimization Platforms",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-09-18T14:22:20.794Z",
  "verifiedVitals": {
    "website": "https://alchemi.bio",
    "category": "AI platform for drug development in life sciences",
    "what_it_does": "Alchemi develops AI agents that accelerate R&D through automation, compliance, and seamless integration. It provides an AI platform for regulated development, offering solutions for regulatory authoring, AI-assisted review, and shared spaces across all phases of drug development, including non-clinical, clinical, bioanalysis, CMC, regulatory submissions, and safety.",
    "primary_audience": "Pharmaceutical companies, biotechnology companies, and development partners, including top-five global CROs.",
    "core_product": "An AI platform for regulated drug development, featuring AI agents for pharmaceutical research and clinical workflow optimization, regulatory authoring, AI-assisted review, and shared spaces.",
    "named_competitors": [
      "Veeva Systems",
      "Isomorphic Labs",
      "Persist AI",
      "ChemT Biotechnology"
    ]
  },
  "intentTags": {
    "problemIntents": [
      "Slow drug development timelines",
      "Inefficient regulatory documentation and authoring processes",
      "Manual and time-consuming QC/QA review",
      "Challenges with compliance in regulated drug development",
      "Difficulty analyzing thousands of documents securely",
      "Lack of specialized AI solutions for life sciences workflows",
      "Data security and privacy concerns with general AI tools"
    ],
    "solutionIntents": [
      "Accelerate drug development timelines",
      "Automate regulatory authoring and documentation",
      "Streamline AI-assisted review and quality assurance",
      "Ensure GxP and 21 CFR Part 11 compliance with AI",
      "Secure collaborative environments for document analysis",
      "Deploy specialized AI agents for scientific workflows",
      "Improve data security and privacy in AI applications"
    ],
    "evaluationIntents": [
      "Evaluate AI platform for regulatory compliance (GxP, 21 CFR Part 11)",
      "Assess AI accuracy and performance compared to general AI models",
      "Review AI platform's data security and privacy practices (no customer data training)",
      "Examine integration capabilities with existing systems",
      "Seek proven results for turnaround time and QA cycle reductions",
      "Compare specialized AI solutions for clinical pharmacology"
    ]
  },
  "businessProfileClaims": [],
  "timestamp": 1789860275664
}